Institutional Ownership
Oruka Therapeutics Inc
CUSIP 687604108COMORKAQ1 2026
13D / 13G Filings
22
Schedule 13D/13G on record
Beneficial Filers
12
Distinct reporting persons
Largest Stake
20.0%
Max % of class reported
Institutional Holders
177
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
22 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Rtw Investments, LP | 13G/A | 4.3% | 2.06M | SEC |
| 2 | Feb 13, 2026 | Deep Track Capital, LP | 13G/A | 4.5% | 2.16M | SEC |
| 3 | Jan 30, 2026 | The Vanguard Group | 13G | 5.1% | 2.45M | SEC |
| 4 | Jan 21, 2026 | Blackrock, Inc. | 13G | 6.6% | 3.18M | SEC |
| 5 | Nov 14, 2025 | Venrock Healthcare Capital Partners III, L.P. | 13G/A | 9.9% | 4.91M | SEC |
| 6 | Oct 17, 2025 | Blackrock, Inc. | 13G/A | 4.5% | 2.20M | SEC |
| 7 | Sep 24, 2025 | Viking Global Investors LP | 13G | 5.5% | 2.67M | SEC |
| 8 | Sep 19, 2025 | Fairmount Funds Management LLC | 13D/A | 20.0% | — | SEC |
| 9 | Jul 17, 2025 | Blackrock, Inc. | 13G | 5.3% | 1.99M | SEC |
| 10 | May 15, 2025 | Rtw Investments, LP | 13G | 5.2% | 1.95M | SEC |
12 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Oruka Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Fmr LLC | 7.43M | $364.51M |
| 2 | Venrock Adviser, LLC | 4.15M | $203.48M |
| 3 | Fairmount Funds Management LLC | 3.71M | $181.74M |
| 4 | Blackrock, Inc. | 3.53M | $173.00M |
| 5 | Viking Global Investors LP | 2.67M | $130.80M |
| 6 | Paradigm Biocapital Advisors LP | 2.32M | $113.81M |
| 7 | Rtw Investments, LP | 2.06M | $100.95M |
| 8 | Deep Track Capital, LP | 2.03M | $99.78M |
| 9 | State Street Corp | 1.61M | $79.14M |
| 10 | Remedium Capital Partners, LLC | 1.57M | $76.80M |